Cognitive intranasal

Adamax

By Hack SmithLast updated: How we research

Enhances brain adaptability and mental performance

Common Uses
  • Neuroplasticity
  • Cognitive Enhancement
Evidence Grade
E — Community — Anecdotal reports
No direct peer-reviewed evidence exists for Adamax.
Safety Notes

NO PUBLISHED HUMAN CLINICAL TRIALS EXIST FOR ADAMAX - all safety information is extrapolated from Semax research or derived from unverified community reports Adamax is a proprietary acetylated modification of Semax (ACTH 4-7 Pro-Gly-Pro analog) - the structural changes may meaningfully alter potency, duration, bioavailability, and safety profile in ways that have not been studied Not approved by FDA, EMA, or other major regulatory agencies for any indication Semax research suggests immune-modulatory and neurotrophic effects - individuals with autoimmune conditions, cancer history, or psychiatric disorders should exercise extreme caution Long-term safety data does not exist for either Adamax or its parent compound Semax in Western clinical literature

Mechanism of Action

Adamax is a proprietary modified peptide based on Semax, which is itself derived from the ACTH(4-7) fragment with a Pro-Gly-Pro C-terminal extension. Based on Semax research, the core mechanism likely involves upregulation of brain-derived neurotrophic factor (BDNF) and modulation of neurotrophic signaling pathways that support neuronal survival and synaptic plasticity. However, the specific structural modifications distinguishing Adamax from Semax are not documented in peer-reviewed literature, and these modifications may meaningfully alter its pharmacological profile. Key Pathways: BDNF/TrkB neurotrophic signaling (extrapolated from Semax research), Melanocortin receptor modulation (extrapolated from Semax research), Monoaminergic neurotransmission enhancement (extrapolated from Semax research) Community reports suggest Adamax may provide cognitive enhancement effects similar to but potentially more pronounced than Semax, with users reporting improved focus, mental clarity, and reduced anxiety. The intranasal delivery route theoretically allows direct CNS access via olfactory pathways, similar to established Semax protocols. These reported effects remain unverified by clinical research, and individual responses may vary significantly from Semax due to unknown structural modifications.

Common Dose Reference Ranges

Educational reference ranges only — discuss actual dosing with a qualified healthcare provider.

Low
100
mcg
Standard
150
mcg
High
200
mcg
🔬 Related compounds
P-21HumaninSemax
🔒 Skool Members Only

Full Adamax protocols — frequency, timing, cycle length, reconstitution & research

Frequency: 5 days on/2 off, every other day, or as needed
Half-life: Estimated 3-5 minutes (extrapolated from Semax data)
Cycle length: 6 weeks
Side Effects
  • Nasal irritation
  • Headache
  • Fatigue or drowsiness
  • Nasal dryness
  • Mood changes
  • Hair shedding
Compatible Stacks
Join Skool to unlock full Adamax data →